Kiora Pharmaceuticals Inc Stock Ownership - Who owns Kiora Pharmaceuticals?

Insider buying vs selling

Have Kiora Pharmaceuticals Inc insiders been buying or selling?
Eric Joseph DanielsChief Development Officer2024-06-141,431$5.29
Melissa ToscaEVP Finance2024-06-14100$5.25
Erin ParsonsDirector2024-06-135,260$4.88
Brian M. StremPresident and CEO2024-06-133,000$5.00

1 of 1

KPRX insiders have bought more... subscribe to Premium to read more.
Net Insider Buy/Sell (L12M) Ownership

Be the first to know when KPRX insiders and whales buy or sell their stock.

KPRX Shareholders

What type of owners hold Kiora Pharmaceuticals Inc stock?
Armistice Capital LLC256.34%7,478,202$40.08MInsider
Rosalind Advisors Inc78.84%2,300,000$12.33MInstitution
Aigh Capital Management LLC78.84%2,300,000$12.33MInstitution
Alyeska Investment Group LP75.41%2,200,000$11.79MInstitution
Nantahala Capital Management LLC65.13%1,900,000$10.18MInstitution
Innoven Partenaires Sa Ipsa50.06%1,460,479$7.83MInsider
Ventech Capital Ii49.08%1,431,814$7.67MInsider
Velan Capital Investment Management LP37.71%1,100,000$5.90MInstitution
Adar1 Capital Management LLC37.71%1,100,000$5.90MInstitution
Private Equity Natixis23.11%674,205$3.61MInsider

1 of 3

KPRX vs Biotech Stocks

TickerInst. %Insider %Net Insider (L12M)Net Insider (L3M)
KPRX47.72%52.28%Net BuyingNet Buying
SNSE9.21%71.96%Net Selling
TRAW6.10%93.90%Net Selling

Kiora Pharmaceuticals Stock Ownership FAQ

Who owns Kiora Pharmaceuticals?

Kiora Pharmaceuticals (NASDAQ: KPRX) is owned by 382.05% institutional shareholders, 418.57% Kiora Pharmaceuticals insiders, and 0.00% retail investors. Armistice Capital LLC is the largest individual Kiora Pharmaceuticals shareholder, owning 7.48M shares representing 256.34% of the company. Armistice Capital LLC's Kiora Pharmaceuticals shares are currently valued at $40.08M.

If you're new to stock investing, here's how to buy Kiora Pharmaceuticals stock.
WallStreetZen does not provide financial advice and does not issue recommendations or offers to buy stock or sell any security.

Information is provided 'as-is' and solely for informational purposes and is not advice. WallStreetZen does not bear any responsibility for any losses or damage that may occur as a result of reliance on this data.